000 01156 a2200337 4500
005 20250515092808.0
264 0 _c20080124
008 200801s 0 0 eng d
022 _a1396-0296
024 7 _a10.1111/j.1529-8019.2007.00139.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChacko, Manju
245 0 0 _aEfalizumab.
_h[electronic resource]
260 _bDermatologic therapy
_c
300 _a265-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlopecia Areata
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aCD11a Antigen
_xmetabolism
650 0 4 _aCell Migration Inhibition
650 0 4 _aDermatitis, Atopic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLichen Planus, Oral
_xdrug therapy
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aSkin Diseases
_xdrug therapy
700 1 _aWeinberg, Jeffrey M
773 0 _tDermatologic therapy
_gvol. 20
_gno. 4
_gp. 265-9
856 4 0 _uhttps://doi.org/10.1111/j.1529-8019.2007.00139.x
_zAvailable from publisher's website
999 _c17489562
_d17489562